In contrast, EPIC and TIMER showed fewer significant differences, with EPIC showing significance only in cancer-associated fibroblasts and macrophages, and TIMER in T cell CD4+, neutrophils, macrophages, and myeloid dendritic cells. The gene discussed is CD4; the disease is cancer.